OPKO HEALTH, INC. (OPK)
CIK 944809 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 746.3M shares as of Jul 17, 2026 (10-Q).
Cash runway
Funded — but tight
~20 months of cash · watch
Full breakdown: cash runway tool · source filing →
Warrants
Warrants outstanding: 1.0M underlying shares, as reported Aug 31, 2011 (10-Q).
Rough fully diluted estimate: 747.3M = 746.3M O/S + 1.0M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
| Note | Principal | Carrying | Conv. price | Rate | If converted |
|---|---|---|---|---|---|
| the 2029 Convertible Notes 1 | $230.0M | — | $1.15 | 3.75% | ~200.0M sh |
| the 2029 Convertible 144 A Notes | not tagged | $121.4M | not tagged | — | — |
| the 2029 Convertible Notes | not tagged | $89.8M | not tagged | — | — |
| the 2029 Convertible Affiliate Notes | $71.1M | — | not tagged | 3.75% | — |
| the 2023 Convertible Notes | $55.0M | — | not tagged | — | — |
If every note above converted at its tagged price: ~200.0M new shares on 746.3M currently outstanding. An estimate from principal ÷ conversion price, with inputs carrying different as-of dates; make-whole adjustments, capped calls and partial repurchases are not modeled.
Notes exactly as the company dimensioned them in its 10-Q filed Jul 27, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 746.3M | Jul 17, 2026 |
| + Warrants (aggregate, as tagged) (if exercised) | 1.0M | Aug 31, 2011 |
| + the 2029 Convertible Notes 1 (if fully converted) | 200.0M | Jan 9, 2024 |
| Fully diluted estimate | 947.3M | +26.9% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Last 12 months: 0 executed · 0 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full OPK workspace